BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• BioMidwest

  Nutriband Inc. to Ring NASDAQ Stock Market Opening Bell on December 3, 2021

  Nutriband Inc. announced that its Chief Executive Officer Gareth Sheridan and President Serguei Melnik will be joined by members of the Company’s board of directors and senior management to ring the NASDAQ Stock Market Opening Bell at 9:30 a.m. EST on Friday, December 3, 2021.

  December 3, 2021

   · 

  3 min read
• Spectral to Present at the SNN Network Canada Virtual Event on Wednesday, December 8, 2021

  Spectral Medical Inc. today announced that Chris Seto, Chief Executive Officer of Spectral Medical, is scheduled to present at the SNN Network Canada Virtual Event taking place on December 7-9, 2021.

  December 3, 2021

   · 

  3 min read
• Pharm Country

  SK life science Presents Long-Term Data of XCOPRI® (cenobamate tablets) CV in Adults with Partial-Onset Seizures at the American Epilepsy Society 2021 Annual Meeting

  SK Life Science, Inc. will present new post-hoc, retrospective analyses of the long-term safety and efficacy of its anti-seizure medication (ASM) XCOPRI® (cenobamate tablets) CV at the American Epilepsy Society (AES) Annual Meeting, held December 3-7, 2021 in Chicago, Illinois.

  December 3, 2021

   · 

  12 min read
• Psyence to Present at the H.C Wainwright 2nd Annual Psychedelics Conference December 6

  Psyence Group Inc. is pleased to announce that Psyence Chief Executive Officer, Neil Maresky, will be presenting at the virtual H.C. Wainwright 2nd Annual Psychedelics Conference on December 6th , 2021.

  December 3, 2021

   · 

  3 min read
• BioMidwest

  Marizyme Announces Expansion of Patent Portfolio Into Several Key Territories

  Marizyme Inc. announced that it has received notice of allowance for foundational patent applications for two of its core technologies in several key markets further strengthening the company’s intellectual property.

  December 3, 2021

   · 

  3 min read
• Genetown

  Stoke Therapeutics Presents Data from the Phase 1/2a MONARCH Study of STK-001 in Children and Adolescents with Dravet Syndrome at the American Epilepsy Society (AES) 2021 Annual Meeting

  Stoke Therapeutics, Inc. today announced highlights from five presentations related to the ongoing clinical development of STK-001 being made at the American Epilepsy Society (AES) 2021 Annual Meeting, December 3 – 7.

  December 3, 2021

   · 

  14 min read
• Business

  Applied DNA Schedules Fourth Quarter and Full Fiscal Year 2021 Financial Results Conference Call and Webcast for Thursday, December 9, 2021

  Applied DNA Sciences, Inc. today announced that it will report its fourth quarter and full fiscal year 2021 financial results after market close on Thursday, December 9, 2021.

  December 3, 2021

   · 

  3 min read
• Henlius’ 4th Biologics: Bevacizumab Biosimilar Hanbeitai Approved by National Medical Products Administration

  Shanghai Henlius Biotech, Inc. (2696.HK) announced that bevacizumab biosimilar Hanbeitai, developed and manufactured by Henlius independently, has been approved by the National Medical Products Administration (NMPA).

  December 3, 2021

   · 

  5 min read
• Pharm Country

  Marinus Pharmaceuticals Announces New Clinical and Research Data to be Presented at American Epilepsy Society Meeting

  Marinus Pharmaceuticals, Inc. today announced new clinical trial and research data being presented at the American Epilepsy Society (AES) Annual Meeting in Chicago, Illinois.

  December 3, 2021

   · 

  12 min read